Loss of BAP1 protein expression is an independent marker of poor prognosis in patients with low-risk clear cell renal cell carcinoma. Cancer doi: 10.1002/cncr.28521., , , , , , , , , , .
The authors regret that they identified several errors in the manuscript after they approved the final proofs. The corrections are underlined or commented on below.
In the MATERIALS AND METHODS section, first paragraph under Patient Selection, fourth line should read “between 1990 and 2009.”
In the MATERIALS AND METHODS section, first paragraph under Statistical Methods, the following text should be deleted, “adjusting for the competing risk of death due to other causes.”
In the RESULTS section, first paragraph under Association of BAP1 With Clinical and Pathologic Characteristics, a sentence should be revised to read “A total of 1092 patients who did not die from RCC (and were thus censored) had a mean of 8.3 years of follow up (median, 7.7 years; range, 0.003-22.1 years).”
In the RESULTS section, paragraph under Multivariable Analysis of BAP1 With ccRCCSpecific Death, final CI should read “95% CI = 1.24-2.25.”
In the RESULTS section, paragraph under Impact of BAP1 Expression on ccRCC-Specific Death in Low-, Intermediate-, and High-Risk Groups, data should be adjusted as follows, “… and SSIGN≥8 (n = 70, 48 events). We then … (HR = 3.24; 95% C = 1.26-8.33; P = .015) (Fig. 3). BAP1 SIGN≥8 cohorts…”
Figure 3 has been modified to account for the correct numbers in each cohort. The graphs, HR, and P-value have not changed. The Figure 3 legend should now read:
Kaplan-Meier estimate … SSIGN≥8 scores. (A) In the … were SSIGN 4-7 and SSIGN≥8.
The authors regret these errors.